Free Trial

Stereotaxis Q4 2022 Earnings Report

Stereotaxis logo
$2.19 -0.10 (-4.37%)
As of 02/21/2025 04:10 PM Eastern

Stereotaxis EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.06
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Stereotaxis Revenue Results

Actual Revenue
$7.30 million
Expected Revenue
$9.60 million
Beat/Miss
Missed by -$2.30 million
YoY Revenue Growth
N/A

Stereotaxis Announcement Details

Quarter
Q4 2022
Time
N/A

STXS Upcoming Earnings

Stereotaxis will be holding an earnings conference call on Monday, March 3 at 8:30 AM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

Stereotaxis Earnings Headlines

Stock Market Sleeps On Stereotaxis MAGiC CE Mark
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.
TD Cowen Keeps Their Buy Rating on Stereotaxis (STXS)
TD Cowen Reaffirms Their Buy Rating on Stereotaxis (STXS)
See More Stereotaxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stereotaxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stereotaxis and other key companies, straight to your email.

About Stereotaxis

Stereotaxis (NYSEAMERICAN:STXS) designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

View Stereotaxis Profile

More Earnings Resources from MarketBeat